Erythema Chronicum Migrans
"Erythema Chronicum Migrans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A deep type of gyrate erythema that follows a bite by an ixodid tick; it is a stage-1 manifestation of LYME DISEASE. The site of the bite is characterized by a red papule that expands peripherally as a nonscaling, palpable band that clears centrally. This condition is often associated with systemic symptoms such as chills, fever, headache, malaise, nausea, vomiting, fatigue, backache, and stiff neck.
| Descriptor ID |
D015787
|
| MeSH Number(s) |
C01.252.400.155.569.200 C01.252.400.825.480.400 C01.252.825.310 C01.252.847.193.569.200 C01.539.800.720.310 C17.800.229.200 C17.800.838.765.310
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Erythema Chronicum Migrans".
Below are MeSH descriptors whose meaning is more specific than "Erythema Chronicum Migrans".
This graph shows the total number of publications written about "Erythema Chronicum Migrans" by people in this website by year, and whether "Erythema Chronicum Migrans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Erythema Chronicum Migrans" by people in Profiles.
-
Wormser GP, McKenna D, Jacobson E, Shanker EM, Shaffer KD, Scavarda C, Visintainer P. Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment. Antimicrob Agents Chemother. 2020 12 16; 65(1).
-
Wormser GP, McKenna D, Karmen CL, Shaffer KD, Silverman JH, Nowakowski J, Scavarda C, Shapiro ED, Visintainer P. Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months. Clin Infect Dis. 2020 12 15; 71(12):3118-3124.
-
Wormser GP, Park K, Madison C, Rozenberg J, McKenna D, Scavarda C, Karmen C, Dornbush R, Visintainer P. Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second Edition. Am J Med. 2019 04; 132(4):519-524.
-
Strle F, Stupica D, Bogovi? P, Visintainer P, Wormser GP. Is the risk of early neurologic Lyme borreliosis reduced by preferentially treating patients with erythema migrans with doxycycline? Diagn Microbiol Infect Dis. 2018 Jun; 91(2):156-160.
-
Nowakowski J, McKenna D, Nadelman RB, Bittker S, Cooper D, Pavia C, Holmgren D, Visintainer P, Wormser GP. Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis. 2009 Dec 01; 49(11):1733-5.
-
Wormser GP, Kaslow R, Tang J, Wade K, Liveris D, Schwartz I, Klempner M. Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme disease. J Infect Dis. 2005 Dec 01; 192(11):2020-6.
-
Zhao Z, Chang H, Trevino RP, Whren K, Bhawan J, Klempner MS. Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease. J Infect Dis. 2003 Oct 15; 188(8):1098-104.
-
Wormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P, Dornbush R, Singh B, Nadelman RB. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003 May 06; 138(9):697-704.